# Trial of Cytoreductive Surgery and HIPEC in Patients With Primary and Secondary Peritoneal Cancers

> **NCT03604653** · — · COMPLETED · sponsor: **Holy Name Medical Center, Inc.** · enrollment: 10 (actual)

## Conditions studied

- Stomach Cancer
- Colorectal Cancer
- Appendiceal Cancer
- Ovarian Cancer
- Uterine Cancer
- Cervical Cancer
- Fallopian Tube Cancer
- Primary Peritoneal Carcinoma

## Interventions

- **DEVICE:** HIPEC
- **DRUG:** Mitomycin c
- **DRUG:** CDDP 50
- **DRUG:** CDDP 75
- **DRUG:** Doxorubicin

## Key facts

- **NCT ID:** NCT03604653
- **Lead sponsor:** Holy Name Medical Center, Inc.
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2018-05-15
- **Primary completion:** 2021-05-01
- **Final completion:** 2021-05-01
- **Target enrollment:** 10 (ACTUAL)
- **Last updated:** 2022-08-03


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03604653

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03604653, "Trial of Cytoreductive Surgery and HIPEC in Patients With Primary and Secondary Peritoneal Cancers". Retrieved via AI Analytics 2026-06-03 from https://api.ai-analytics.org/clinical/NCT03604653. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*